Results 91 to 100 of about 542,620 (267)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Theoretical Analysis and Experimental Verification of Particle Damper-Based Energy Dissipation with Applications to Reduce Structural Vibration

Shock and Vibration, 2015
Particle damping technology can greatly reduce vibration of equipment and structure through friction and inelastic collisions of particles. An energy dissipation model for particle damper has been presented based on the powder mechanics and the collision
Wangqiang Xiao, Lina Jin, Binqiang Chen
doaj   +1 more source

A Language Model for Particle Tracking

CoRR
Particle tracking is crucial for almost all physics analysis programs at the Large Hadron Collider. Deep learning models are pervasively used in particle tracking related tasks. However, the current practice is to design and train one deep learning model for one task with supervised learning techniques.
Andris Huang, Yash Melkani, Paolo Calafiura, Alina Lazar, Daniel Thomas Murnane, Minh-Tuan Pham, Xiangyang Ju   +6 more
openaire   +2 more sources

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Modeling Dense Particle Flow in Multistage and Obstructed Flow Receivers Using High Fidelity Simulations

SolarPACES Conference Proceedings
Particles are a leading contender for next-generation, concentrating solar power technologies, and the design of the particle receiver is critical to minimize the levelized cost of electricity.
Brantley Mills, Flint Pierce, Eldwin Djajadiwinata, Rageh Saeed, Shaker Alaqel, Nader Saleh   +5 more
doaj   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

Microscale Modeling of Frozen Particle Fluid Systems with a Bonded-Particle Model Method. [PDF]

Materials (Basel), 2022
Chan TT, Heinrich S, Grabe J, Dosta M.
europepmc   +1 more source

C2α‐carbanion‐protonating glutamate discloses tradeoffs between substrate accommodation and reaction rate in actinobacterial 2‐hydroxyacyl‐CoA lyase

FEBS Open Bio, EarlyView.
Enzymes of the 2‐hydroxyacyl‐CoA lyase group catalyze the condensation of formyl‐CoA with aldehydes or ketones. Thus, by structural adaptation of active sites, practically any pharmaceutically and industrially important 2‐hydroxyacid could be biotechnologically synthesized. Combining crystal structure analysis, active site mutations and kinetic assays,
Michael Zahn, Barbara Seroka, Ryszard Lazny, Zenon Lotowski, Thore Rohwerder   +4 more
wiley   +1 more source

Balanced Standing on One Foot of Biped Robot Based on Three-Particle Model Predictive Control. [PDF]

Biomimetics (Basel), 2022
Yang Y, Shi J, Huang S, Ge Y, Cai W, Li Q, Chen X, Li X, Zhao M.   +8 more
europepmc   +1 more source